AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 1-25/52
CHRONIC HEPATITIS-B AND HEPATITIS-C IN HI V-INFECTED PATIENTS
Authors: OPRAVIL M HUNZIKER R LUTHY R GROB PJ
Citation: M. Opravil et al., CHRONIC HEPATITIS-B AND HEPATITIS-C IN HI V-INFECTED PATIENTS, Deutsche Medizinische Wochenschrift, 123(24), 1998, pp. 753-760
IMPROVEMENT IN IMMUNE FUNCTION DUE TO TREATMENT WITH INDINAVIR DESPITE SEVERE IMMUNE-DEFICIENCY
Authors: ROTHEN M BISSET LR JOLLERJEMELKA HI GROB P LUTHY R OPRAVIL M
Citation: M. Rothen et al., IMPROVEMENT IN IMMUNE FUNCTION DUE TO TREATMENT WITH INDINAVIR DESPITE SEVERE IMMUNE-DEFICIENCY, Antiviral therapy, 3(3), 1998, pp. 159-167
PREDICTION OF HIV-1 RNA SUPPRESSION AND ITS DURABILITY DURING TREATMENT WITH ZIDOVUDINE LAMIVUDINE/
Authors: OPRAVIL M HILL AM DEMASI R DAWSON D
Citation: M. Opravil et al., PREDICTION OF HIV-1 RNA SUPPRESSION AND ITS DURABILITY DURING TREATMENT WITH ZIDOVUDINE LAMIVUDINE/, Antiviral therapy, 3(3), 1998, pp. 169-176
FREQUENT CHRONIC HEPATITIS-B VIRUS-INFECTION IN HIV-INFECTED PATIENTSPOSITIVE FOR ANTIBODY TO HEPATITIS-B CORE ANTIGEN ONLY
Authors: HOFER M JOLLERJEMELKA HI GROB PJ LUTHY R OPRAVIL M
Citation: M. Hofer et al., FREQUENT CHRONIC HEPATITIS-B VIRUS-INFECTION IN HIV-INFECTED PATIENTSPOSITIVE FOR ANTIBODY TO HEPATITIS-B CORE ANTIGEN ONLY, European journal of clinical microbiology & infectious diseases, 17(1), 1998, pp. 6-13
A PLACEBO-CONTROLLED TRIAL OF DIDANOSINE PLUS STAVUDINE, WITH AND WITHOUT HYDROXYUREA, FOR HIV-INFECTION
Authors: RUTSCHMANN OT OPRAVIL M ITEN A MALINVERNI R VERNAZZA PL BUCHER HC BERNASCONI E SUDRE P LEDUC D YERLY S PERRIN LH HIRSCHEL B
Citation: Ot. Rutschmann et al., A PLACEBO-CONTROLLED TRIAL OF DIDANOSINE PLUS STAVUDINE, WITH AND WITHOUT HYDROXYUREA, FOR HIV-INFECTION, AIDS, 12(8), 1998, pp. 71-77
LEVELS OF HIV-INFECTED PERIPHERAL-BLOOD CELLS REMAIN STABLE THROUGHOUT THE NATURAL-HISTORY OF HIV-1 INFECTION
Authors: CONE RW GOWLAND P OPRAVIL M GROB P LEDERGERBER B
Citation: Rw. Cone et al., LEVELS OF HIV-INFECTED PERIPHERAL-BLOOD CELLS REMAIN STABLE THROUGHOUT THE NATURAL-HISTORY OF HIV-1 INFECTION, AIDS, 12(17), 1998, pp. 2253-2260
HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY DURING EARLY HIV-INFECTION REVERSES T-CELL ACTIVATION AND MATURATION ABNORMALITIES
Authors: BISSET LR CONE RW HUBER W BATTEGAY M VERNAZZA PL WEBER R GROB PJ OPRAVIL M
Citation: Lr. Bisset et al., HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY DURING EARLY HIV-INFECTION REVERSES T-CELL ACTIVATION AND MATURATION ABNORMALITIES, AIDS, 12(16), 1998, pp. 2115-2123
IS TREATMENT WITH RITONAVIR A RISK FACTOR FOR MYOCARDIAL-INFARCTION IN HIV-INFECTED PATIENTS
Authors: ERIKSSON U OPRAVIL M AMANN FW SCHAFFNER A
Citation: U. Eriksson et al., IS TREATMENT WITH RITONAVIR A RISK FACTOR FOR MYOCARDIAL-INFARCTION IN HIV-INFECTED PATIENTS, AIDS, 12(15), 1998, pp. 2079-2080
PREDICTORS OF UNPROTECTED SEXUAL CONTACTS IN HIV-INFECTED PERSONS IN SWITZERLAND
Authors: EICHHOCHLI D NIKLOWITZ MW CLEMENT U LUTHY R OPRAVIL M
Citation: D. Eichhochli et al., PREDICTORS OF UNPROTECTED SEXUAL CONTACTS IN HIV-INFECTED PERSONS IN SWITZERLAND, Archives of sexual behavior, 27(1), 1998, pp. 77-90
MENINGITIS AFTER ACUTE BORRELIA-BURGDORFERI INFECTION IN AN HIV-POSITIVE PATIENT
Authors: DUDLE G OPRAVIL M LUTHY R WEBER R
Citation: G. Dudle et al., MENINGITIS AFTER ACUTE BORRELIA-BURGDORFERI INFECTION IN AN HIV-POSITIVE PATIENT, Deutsche Medizinische Wochenschrift, 122(39), 1997, pp. 1178-1180
METAANALYSIS OF PROPHYLACTIC TREATMENTS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA AND TOXOPLASMA ENCEPHALITIS IN HIV-INFECTED PATIENTS
Authors: BUCHER HC GRIFFITH L GUYATT GH OPRAVIL M
Citation: Hc. Bucher et al., METAANALYSIS OF PROPHYLACTIC TREATMENTS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA AND TOXOPLASMA ENCEPHALITIS IN HIV-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 15(2), 1997, pp. 104-114
HIV-ASSOCIATED PRIMARY PULMONARY-HYPERTENSION - A CASE-CONTROL STUDY
Authors: OPRAVIL M PECHERE M SPEICH R JOLLERJEMELKA HI JENNI R RUSSI EW HIRSCHEL B LUTHY R BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U HIRSCHEL B LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: M. Opravil et al., HIV-ASSOCIATED PRIMARY PULMONARY-HYPERTENSION - A CASE-CONTROL STUDY, American journal of respiratory and critical care medicine, 155(3), 1997, pp. 990-995
CYTOMEGALOVIRUS RETINITIS - DECREASED RISK OF BILATERALITY WITH INCREASED USE OF SYSTEMIC TREATMENT
Authors: STALDER N SUDRE P OLMARI M OPRAVIL M GABRIEL V SANSONETTI A VONOVERBECK J HERBORT CP HIRSCHEL B BATTEGAY M BURGISSER P JEANNEROD L EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: N. Stalder et al., CYTOMEGALOVIRUS RETINITIS - DECREASED RISK OF BILATERALITY WITH INCREASED USE OF SYSTEMIC TREATMENT, Clinical infectious diseases, 24(4), 1997, pp. 620-624
IMPACT OF NEW ANTIRETROVIRAL COMBINATION THERAPIES IN HIV-INFECTED PATIENTS IN SWITZERLAND - PROSPECTIVE MULTICENTER STUDY
Authors: EGGER M HIRSCHEL B FRANCIOLI P SUDRE P WIRZ M FLEPP M RICKENBACH M MALINVERNI R VERNAZZA P BATTEGAY M BERNASCONI E BURGISSER P ERB P FIERZ W GROB P GRUNINGER U JEANNEROD L LEDERGERBER B LUTHY R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W PIFFARETTI GC RUTSCHMANN O ZANETTI G
Citation: M. Egger et al., IMPACT OF NEW ANTIRETROVIRAL COMBINATION THERAPIES IN HIV-INFECTED PATIENTS IN SWITZERLAND - PROSPECTIVE MULTICENTER STUDY, BMJ. British medical journal, 315(7117), 1997, pp. 1194-1199
CONDOM BREAKAGE AND PREVENTION OF HIV TRANSMISSION - AN UNDERESTIMATED PROBLEM
Authors: EICHHOCHLI D NIKLOWITZ MW SIEBER M OPRAVIL M LUTHY R
Citation: D. Eichhochli et al., CONDOM BREAKAGE AND PREVENTION OF HIV TRANSMISSION - AN UNDERESTIMATED PROBLEM, International journal of STD & AIDS, 8(1), 1997, pp. 69-70
NATIVE AND PROSTHETIC VALVE ENDOCARDITIS CAUSED BY ROTHIA-DENTOCARIOSA - DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS
Authors: BINDER D ZBINDEN R WIDMER U OPRAVIL M KRAUSE M
Citation: D. Binder et al., NATIVE AND PROSTHETIC VALVE ENDOCARDITIS CAUSED BY ROTHIA-DENTOCARIOSA - DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS, Infection, 25(1), 1997, pp. 22-26
EPIDEMIOLOGIC AND CLINICAL ASPECTS OF MYCOBACTERIAL INFECTIONS
Authors: OPRAVIL M
Citation: M. Opravil, EPIDEMIOLOGIC AND CLINICAL ASPECTS OF MYCOBACTERIAL INFECTIONS, Infection, 25(1), 1997, pp. 56-59
DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX DISEASE IN THE SWISS HIV COHORT STUDY - INCREASING INCIDENCE, UNCHANGED PROGNOSIS
Authors: LOW N PFLUGER D EGGER M BATTEGAY M BERNASCONI E BURGISSER P ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U HIRSCHEL B JEANNEROD L LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W PIFFARETTI GC RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: N. Low et al., DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX DISEASE IN THE SWISS HIV COHORT STUDY - INCREASING INCIDENCE, UNCHANGED PROGNOSIS, AIDS, 11(9), 1997, pp. 1165-1171
SIMPLE MONITORING OF ANTIRETROVIRAL THERAPY WITH A SIGNAL-AMPLIFICATION-BOOSTED HIV-1 P24 ANTIGEN-ASSAY WITH HEAT-DENATURED PLASMA
Authors: BONI J OPRAVIL M TOMASIK Z ROTHEN M BISSET K GROB PJ LUTHY R SCHUPBACH J
Citation: J. Boni et al., SIMPLE MONITORING OF ANTIRETROVIRAL THERAPY WITH A SIGNAL-AMPLIFICATION-BOOSTED HIV-1 P24 ANTIGEN-ASSAY WITH HEAT-DENATURED PLASMA, AIDS, 11(6), 1997, pp. 47-52
CHANGE IN CIRCULATING LEVELS OF THE CHEMOKINES MACROPHAGE INFLAMMATORY PROTEINS 1-ALPHA AND 1-BETA, RANTES, MONOCYTE CHEMOTACTIC PROTEIN-1 AND INTERLEUKIN-16 FOLLOWING TREATMENT OF SEVERELY IMMUNODEFICIENT HIV-INFECTED INDIVIDUALS WITH INDINAVIR
Authors: BISSET LR ROTHEN M JOLLERJEMELKA HI DUBS RW GROB PJ OPRAVIL M
Citation: Lr. Bisset et al., CHANGE IN CIRCULATING LEVELS OF THE CHEMOKINES MACROPHAGE INFLAMMATORY PROTEINS 1-ALPHA AND 1-BETA, RANTES, MONOCYTE CHEMOTACTIC PROTEIN-1 AND INTERLEUKIN-16 FOLLOWING TREATMENT OF SEVERELY IMMUNODEFICIENT HIV-INFECTED INDIVIDUALS WITH INDINAVIR, AIDS, 11(4), 1997, pp. 485-491
TOXICITY, EFFICACY, PLASMA DRUG CONCENTRATIONS AND PROTEASE MUTATIONSIN PATIENTS WITH ADVANCED HIV-INFECTION TREATED WITH RITONAVIR PLUS SAQUINAVIR
Authors: LORENZI P YERLY S ABDERRAKIM K FATHI M RUTSCHMANN OT VONOVERBECK J LEDUC D PERRIN L HIRSCHEL B BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: P. Lorenzi et al., TOXICITY, EFFICACY, PLASMA DRUG CONCENTRATIONS AND PROTEASE MUTATIONSIN PATIENTS WITH ADVANCED HIV-INFECTION TREATED WITH RITONAVIR PLUS SAQUINAVIR, AIDS, 11(12), 1997, pp. 95-99
RANDOMIZED TRIAL OF ADDITION OF LAMIVUDINE OR LAMIVUDINE PLUS LOVIRIDE TO ZIDOVUDINE-CONTAINING REGIMENS FOR PATIENTS WITH HIV-1 INFECTION - THE CAESAR TRIAL
Authors: COOPER DA KATLAMA C MONTANER J COLLIS PJ ANTUNES F ATKINSON M CLARK A CLUMECK N COLLIS P GAZZARD B GERSTOFT J GOH L HILL A KORSIA S LANGE J MCCALLUM L MCDADE H MALLOLAS J MORONI M NORKRANS G OPRAVIL M REISS P ROZENBAUM W SCOTT J SMITH D STASZEWSKI S STOFFELS P
Citation: Da. Cooper et al., RANDOMIZED TRIAL OF ADDITION OF LAMIVUDINE OR LAMIVUDINE PLUS LOVIRIDE TO ZIDOVUDINE-CONTAINING REGIMENS FOR PATIENTS WITH HIV-1 INFECTION - THE CAESAR TRIAL, Lancet, 349(9063), 1997, pp. 1413-1421
INDINAVIR URINARY STONES AS ORIGIN OF UPPER URINARY-TRACT OBSTRUCTION
Authors: JOHN H MULLER NJ OPRAVIL M HAURI D
Citation: H. John et al., INDINAVIR URINARY STONES AS ORIGIN OF UPPER URINARY-TRACT OBSTRUCTION, Urologia internationalis, 59(4), 1997, pp. 257-259
GENETIC-POLYMORPHISM OF CCR5 GENE AND HIV DISEASE - THE HETEROZYGOUS (CCR5 DELTA-CCR5) GENOTYPE IS NEITHER ESSENTIAL NOR SUFFICIENT FOR PROTECTION AGAINST DISEASE PROGRESSION/
Authors: MORAWETZ RA RIZZARDI GP GLAUSER D RUTSCHMANN O HIRSCHEL B PERRIN L OPRAVIL M FLEPP M VONOVERBECK J GLAUSER MP GHEZZI S VICENZI E POLI G LAZZARIN A PANTALEO G
Citation: Ra. Morawetz et al., GENETIC-POLYMORPHISM OF CCR5 GENE AND HIV DISEASE - THE HETEROZYGOUS (CCR5 DELTA-CCR5) GENOTYPE IS NEITHER ESSENTIAL NOR SUFFICIENT FOR PROTECTION AGAINST DISEASE PROGRESSION/, European Journal of Immunology, 27(12), 1997, pp. 3223-3227
ARE IMMUNOLOGICAL MARKERS, SOCIAL AND PERSONAL RESOURCES, OR A COMPLAINT-FREE STATE PREDICTORS OF PROGRESSION AMONG HIV-INFECTED PATIENTS
Authors: EICHHOCHLI D NIKLOWITZ MW LUTHY R OPRAVIL M
Citation: D. Eichhochli et al., ARE IMMUNOLOGICAL MARKERS, SOCIAL AND PERSONAL RESOURCES, OR A COMPLAINT-FREE STATE PREDICTORS OF PROGRESSION AMONG HIV-INFECTED PATIENTS, Acta psychiatrica Scandinavica, 95(6), 1997, pp. 476-484
Risultati: 1-25 | 26-50 | 51-52